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Cocaine Blocks Effects of Hunger
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Abstract
Despite ancient knowledge on cocaine appetite-suppressant action, the
molecular basis of such fact hunger prevention remains unknown.
Addiction/eating disorders (e.g., binge eating, anorexia, bulimia) share a
central control involving reward circuits. However, we here show that the
sigma-1 receptor (σ R) mediates cocaine anorectic effects by interacting in
neurons with growth/hormone/secretagogue (ghrelin) receptors. Cocaine
increases colocalization of σ R and GHS-R1a at the cell surface. Moreover,
in transfected HEK-293T and neuroblastoma SH-SY5Y cells, and in primary
neuronal cultures, pretreatment with cocaine or a σ R agonist inhibited
ghrelin-mediated signaling, in a similar manner as the GHS-R1a antagonist
YIL-781. Results were similar in G protein-dependent (cAMP accumulation
and calcium release) and in partly dependent or partly independent (ERK1/2
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interaction between receptors and the functional consequences, as well as
Apart from solid evidence of direct interaction between receptors and the
functional consequences, the paper provides a reliable structural model of the
macromolecular σ R-GHS-R1a complex, which arises as a key piece in the
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Introduction
Used today as a recreational drug, cocaine was first consumed by humans in the
form of Coca coca leaves. Indigenous peoples of South America, especially
those living at higher altitude, were aware that chewing Coca coca leaves was
key for keeping helped to keep their life style. For example, Coca Erythroxylum
coca was used to facilitate traversing long distances across the Andes with
reduced weight and little food. Despite such ancient knowledge, i.e., the
appetite suppressant action of cocaine, the molecular basis of hunger prevention
remains unknown. This report was undertaken to test the hypothesis of whether
the well-known anorexigenic effect of cocaine is mediated by growth hormone
secretagogue (GHS) receptors, also known as ghrelin receptors, which are keys
players in the central control of food/energy intake [1].
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Ghrelin, the “hunger” endocrine hormone, is involved in the control of food
intake and energy homeostasis [2]. Its action is mediated by, up-to-date, only
one specific ghrelin receptor that belongs to the superfamily of G protein-
coupled receptors (GPCRs). In humans, this receptor has two isoforms produced
by alternative splicing leads to: isoform 1a that contains seven transmembrane
(TM) domains helices (GHS-R1a, 366 amino acids) and isoform 1b that lacks 6
and 7 TM domains 6 and 7 helices (GHS-R1b, 289 amino acids) [3, 4, 5]. These
TM domains are required for ligand binding and coupling to heterotrimeric G
proteins and, therefore, ghrelin cannot signal via the GHS-R1b receptors
isoform [6]. GHS-R1b seems to serve as a modulator of GHS-R1a surface
expression and signaling [7]. In fact, GHS-R1b is expressed in the same cells as
GHS-R1a, and both isoforms interact to form heteromer receptor signaling units
[6]. We have previously shown that GHS-R1b guides surface expression of
functional GHS-R1a, acting as a dual modulator: low relative GHS-R1b
expression potentiates GHS-R1a function, while high relative GHS-R1b
expression inhibits GHS-R1a function [7]. GHS-R1b negatively influences
ghrelin action by allosteric interactions within the GHS-R1a-GHS-R1b
heteromer that reduce the efficacy of the hormone [6, 8]. Although the purified
GHS-R1a, assembled into lipid discs and it is reportedly coupled to G  [9],
the receptor may also couple to non-G  heterotrimeric G proteins (
www.guidetopharmacology.org ). Indeed, we previously found preferential G
coupling of the GHS-R1a-GHS-R1b complex in HEK-293T cells and
preferential G  coupling in both striatal and hippocampal neurons in culture
[7]. Heteromerization of GHS-R1a and GHS-R1b in heterologous expression
systems is often needed for proper ghrelin-induced signaling. It should be noted
that ghrelin receptors may form direct protein-protein interactions with a variety
of GPCRs, inter alia with dopamine, melanocortin, prostanoid, serotonin,
somatostatin, neurotensin, and GPR83 receptors [10]; see www.gpcr-hetnet.com
and references therein.
The sigma-1 receptor (σ R) is an atypical membrane protein, whose exact
function remains unknown. It has been proposed that it functions as a
pluripotent cell function modulator in living cells [11] that and is attracting a lot
of interest due to its potential as a target against neuropathic pain [12, 13, 14].
While its physiological function remains elusive and the endogenous ligand is
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blocking the interaction of cocaine with σ R have been proposed to reduce
drug-seeking behavior [18]. σ R-mediated cocaine actions in the central
nervous system are dependent on its interactions with GPCRs. For instance, we
have identified that cocaine binding to σ R potentiates dopamine D R-mediated
adenylate cyclase signaling [19, 20] and inhibits D R-mediated signaling in
striatal neurons [20]. ThisThese actions disrupts the delicate balance between
inputs of reward seeking controlled by D R-containing neurons and inputs of
aversion coming from D R-containing neurons. In addition, cocaine binding to
σ R also induces disruption of the orexin and corticotropin-releasing factor
receptor negative cross-talk, playing an important role in the stress-induced
cocaine-seeking behavior [21].
We show in this manuscript that σ R interacts with and modulates the activity
of GHS-R1a, indicating a  a receptor interplay not non-previously
suspected receptor interplay. Moreover, because structural information on
GPCR macromolecular homomeric complexes already exist [22] and the crystal
structure of σ R has been recently elucidated [23], we have devised the
a molecular architecture arrangement consisting of the GHS-R1a-GHS-R1b
heteromer in complex with σ R. We have taken advantage of the recent
knowledge showing that σ R arranges as a homotrimer (each protomer with a
single TM). We used synthetic peptides with the amino acid sequences from the
TM helices of GHS-R1a, together with bimolecular fluorescence
complementation assays and computer modeling, to find the oligomerization
interfaces between GHS-R1a, GHS-R1b, and σ R, and to propose a structural
model of the macromolecular complex.
Materials and Methods
Reagents
Cocaine-chlorhydrate was provided by the Spanish Agencia del Medicamento
(ref no.: 2003C00220). σ R (PRE-084), GHs-R1a (ghrelin and YIL-781), and
A  adenosine receptor (L-phenylisopropyl adenosine, R-PIA, and 1,3-dipropyl-
8-cyclopentylxanthine, DPCPX) ligands were purchased from Tocris, Bristol,
UK. Cocaine-chlorhydrate used for the acute and chronic administration was
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Fusion Proteins and Expression Vectors
Sequences encoding amino acid residues 1–155 and 155–238 of the Venus
variant of yellow fluorescence protein (Venus) were subcloned in the pcDNA3.1
vector to obtain complementary Venus N- and C-hemiproteins. Human cDNAs
for GHS-R1a, GHS-R1b, or σ R were amplified without their stop codons using
sense and antisense primers harboring: EcoRI and KpnI sites to be subcloned in
pcDNA3.1RLuc vector (pRLuc-N1 PerkinElmer, Wellesley, MA) or in a GFP -
containing vector (p-GFP , Packard BioScience, Meridien, CT) to provide σ R-
Rluc, GHS-R1a-Rluc, GHS-R1a-YFP, σ R-YFP, or GHS-R1a-GFP  plasmids.
Human cDNA for A R was subcloned into p-GFP  vector harboring HindIII
and BamHI sites to provide the encoding A -GFP  plasmid. For bimolecular
fluorescence complementation (BiFC) experiments, cDNA for GHS-R1b, GHS-
R1a, and σ R were subcloned into pcDNA3.1-nVenus and pcDNA3.1-cVenus
harboring EcoRI and KpnI sites to provide plasmids encoding GHS-R1b-nYFP,
GHS-R1b-cYFP, GHS-R1a-nYFP, and σ R-cYFP.
Cell Lines, Neuronal Primary Cultures, and Transient
Transfection
HEK-293T human embryonic kidney cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco) supplemented with 2 mM L-glutamine,
100 µg/ml sodium pyruvate, 100 U/ml penicillin/streptomycin, MEM Non-
Essential Amino Acid Solution (1/100) and 5% (v/v) heat-inactivated fetal
bovine serum (FBS) (all supplements were from Invitrogen, Paisley, Scotland,
UK). Primary cultures of striatal neurons were obtained from fetal Sprague
Dawley rats of 19 days. Cells were isolated as described in Hradsky et al.
(2013) and plated at a confluence of 40,000 cells/0.32 cm . Cells were
maintained for 12 days in Neurobasal medium supplemented with 2 mM L-
glutamine, 100 U/ml penicillin/streptomycin, and 2% (v/v) B27 supplement
(GIBCO) in 6-well microplates. Cells were transiently transfected with the
corresponding cDNAs using the PEI (PolyEthylenImine, Sigma-Aldrich, St.
Louis, MO, USA) method or, in the case of the anti-σ R siRNA, with
Lipofectamine 2000 (Thermo Fisher Scientific). After transfection, cells were
incubated in serum-free medium which was replaced by complete medium after
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Immunocytochemistry
HEK-293T cells were fixed in 4% paraformaldehyde for 15 min and washed
with PBS containing 20 mM glycine to quench free aldehyde groups. After
permeabilization with PBS-glycine buffer containing 0.2% Triton X-100 for
5 min, cells were blocked with PBS containing 1% bovine serum albumin (1 h
at room temperature). σ R-YFP was detected by its own fluorescence
(wavelength 530 nm), and Rluc-containing proteins were stained using a mouse
monoclonal anti-Rluc antibody (1/200, 1 h, room temperature, Millipore, CA,
USA) and a Cyn3-conjugated donkey anti-mouse antibody (1/200, Jackson
Immunoresearch Laboratories, West Grove, PA, USA). Nuclei were stained with
Hoechst (1/100, Sigma-Aldrich, St. Louis, USA) and samples were mounted
with Mowiol 30% (Calbiochem) and observed in a Leica SP2 confocal
microscope (Leica Microsystems, Mannheim, Germany).
Resonance Energy Transfer
For bioluminescence energy transfer (BRET) assays, HEK-293T cells were
transiently transfected with a constant amount of cDNA for σ R-Rluc and
increasing amounts of cDNAs for GHS-R1a-GFP  or A -GFP . To normalize
the number of cells, protein concentration was determined using a Bradford
assay kit (Bio-Rad, Munich, Germany) using bovine serum albumin dilutions as
standards. To quantify fluorescence, cell suspensions were distributed in 96-
well microplates (black with transparent bottom), and fluorescence was read in
a Fluostar Optima Fluorimeter (BMG Labtech, Offenburg, Germany) equipped
with a high-energy xenon flash lamp, using a 10 nm bandwidth excitation filter
(400 nm). For BRET measurements, cell suspensions (20 µg protein) were
distributed in 96-well white microplates (Corning 3600, Corning, NY), and
5 µM DeepBlueC (Molecular Probes, Eugene, OR) was added right before
BRET signal acquisition using a Mithras LB 940 reader (Berthold Technologies,
DLReady, Germany). To quantify receptor-Rluc expression, luminescence
readings were performed after 10 min of adding 5 µM coelenterazine H. Net
BRET is defined as [(long-wavelength emission)/(short-wavelength emission)] 
− C , where C  corresponds to [(long-wavelength emission)/(short-wavelength
emission)] for the Rluc protein when expressed individually. For bimolecular
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with a constant amount of cDNA encoding for proteins fused to nVenus or
cVenus and incubated for 4 h in complete DMEM containing the interfering
TAT peptides (with similar sequences to those in TM1 to TM7 of GHS-R1a; see
supplementary Table 1 for sequences). YFP resulting from complementation
was detected by placing cells (20 µg protein) in 96-well microplates (black
plates with a transparent bottom) and reading the fluorescence in a Fluostar
Optima Fluorimeter (BMG Labtech, Offenburg, Germany) using a 30-nm
bandwidth excitation filter (485 nm).
AQ3
Cytosolic cAMP Determination
Forskolin dose-response curves in different density of cells were performed to
select the most appropriate conditions of the assay, which resulted in 5000
HEK-293T cells, 7500 neurons, and 0.5 µM forskolin. Subsequently, assays
were performed in medium containing 50 µM zardaverine, placing cells in 384-
well microplates. This was done by the preincubation with reagents (the σ R
agonist, PRE-084, the GHS-R1a antagonist, YIL-781, or cocaine) for 15 min,
followed by ghrelin addition (100-nM final concentration), and after 15 min
incubation period, 50 µM forskolin was added. Readings were performed
15 min later using a homogeneous time-resolved fluorescence energy transfer
(HTRF) method requiring the Lance Ultra cAMP kit (PerkinElmer) and
fluorescence readings (at 665 nm) in a PHERAstar Flagship microplate reader
equipped with an HTRF optical module (BMG Labtech).
MAPK Activation
To determine ERK1/2 phosphorylation, 40,000 HEK-293 cells/well or 50,000
neurons/well were plated in transparent Deltalab 96-well microplates and kept
in the incubator for 48 h. The medium was substituted by serum-free DMEM
medium 2 to 4 h before starting the experiment. Before the addition of 100 nM,
ghrelin cells were pretreated (10 min at 25 °C) in serum-free medium with
different reagents (the σ R agonist, PRE-084, the GHS-R1a antagonist, YIL-
781, or cocaine). After 7 min of ghrelin-induced activation, cells were washed
twice with cold PBS before the addition of 30 µL of lysis buffer (20 min).
Supernatants (10 µL) were placed in white ProxiPlate 384-well microplates, and
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(Perkin Elmer) and the EnSpire® Multimode Plate Reader (PerkinElmer,
Waltham, MA, USA).
Intracellular Calcium Mobilization
HEK-293T cells were co-transfected with cDNA(s) for receptor(s) and 1 µg
cDNA for the calmodulin-based calcium sensor, GCaMP6 (Chen et al. 2013).
Forty-eight hours after transfection, cells were detached using Mg -free
Locke’s buffer pH 7.4 (154 mM NaCl, 5.6 mM KCl, 3.6 mM NaHCO , 2.3 mM
CaCl , 5.6 mM glucose, and 5 mM HEPES) supplemented with 10 µM glycine.
One hundred fifty thousand cells per well were plated in 96-well black, clear
bottom, microtiter plates. Then, cells were incubated with the σ R agonist,
PRE-084, the GHS-R1a antagonist, YIL-781, or cocaine for 10 min before
ghrelin 100-nM addition. Upon excitation at 488 nm, real-time 515-nm
fluorescence emission due to calcium-ion-complexed GCaMP6 was recorded on
the EnSpire® Multimode Plate Reader (every 5 s, 100 flashes per well).
Label-Free Dynamic Mass Redistribution Assays
HEK-293T cells and neuronal primary cultures were seeded in 384-well sensor
microplates to obtain 70–80% confluent monolayers constituted by 10,000
HEK-293T cells or 14,000 neurons per well. Before the assay, cells were
washed twice with assay buffer (HBSS with 20 mM HEPES and 0.1% DMSO,
pH 7.15) and incubated for 2 h in 40 µL/well of assay-buffer in the reader at
24 °C. Hereafter, the sensor plate was scanned, and a baseline optical signature
was recorded before adding 10 µL of cocaine (30 µM), PRE-084 (100 nM), or
YIL-781 (2 µM) for 30 min followed by ghrelin addition. All compounds were
dissolved in assay buffer. Then, dynamic mass redistribution (DMR) responses
were monitored for at least 3600 s using an EnSpire® Multimode Plate Reader
(PerkinElmer, Waltham, MA, USA). Sensitive measurements of changes in
local optical density mimicking cellular mass movements induced upon receptor
activation were detected using EnSpire Workstation Software v 4.10.
Proximity Ligation Assay
For proximity ligation assays (PLAs), primary cultures of striatal neurons were
fixed in 4% paraformaldehyde for 30 min and permeabilized in PBS containing
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solution, primary cultures were incubated overnight with anti-σ R (1/100, Santa
Cruz Biotechnology, Dallas, USA), and anti-GHS-R1a antibody (1/100,
AbCam, Cambridge, UK) in the presence of Hoechst (1/100, Sigma-Aldrich, St.
Louis, USA) to stain nuclei. Cells were processed using the PLA probes that
bind to the primary antibodies (Duolink II PLA probe anti-Mouse plus and
Duolink II PLA probe anti-Goat minus) and heteroreceptor complex formation
was detected using the Duolink II in situ PLA detection Kit (OLink; Bioscience,
Uppsala, Sweden). Images were taken in a Leica SP2 confocal microscope
(Leica Microsystems, Mannheim, Germany). For each field of view, a stack of
two channels (one per staining), and four to six Z stacks with a step size of
1 µm were acquired. Quantification of the number of cells containing one or
more red dots versus total cells (blue nuclei) and of the number of red dots/cell-
containing dots:r ratio was conducted using a dedicated software known as
Duolink ImageTool (ref: DUO90806, Sigma-Olink). This software has been
developed for PLA signals and cell nuclei quantification in images generated
from fluorescence microscopy.
Cocaine Treatment and Fixation Procedure
Male Sprague-Dawley rats weighing 200–220 g were selected for the
experiments. Rats were kept in controlled environment with 12-h light-dark
cycle at 21 °C room temperature. Food and water were provided ad libitum. All
experimental procedures were approved by the Ethics Committee of the Faculty
of Biological Sciences of “Pontificia Universidad Católica de Chile” and
followed the international guidelines (NIH Guide for the Care and Use of
Laboratory Animals). Rats were divided in two groups of experimental series,
chronic cocaine-treated rats with respective control (saline) and acute cocaine
rats. The chronic cocaine-administration protocol consisted of 15 mg/Kg, i.p.
cocaine injections twice per day for 14 days as described by [24], whereas the
acute cocaine treatment protocol consisted of two injections of 15 mg/kg, i.p.
cocaine, one in the morning and one in the afternoon. Daily administration of
cocaine and saline solution was performed in both experimental series at the
same time in the morning and afternoon (beginning at 11:00 A.M. and 5:00
P.M.). The day after last cocaine injection, rats were deeply anesthetized with
ketamine-xylazine (50–5 mg/kg, respectively) and intracardially perfused with
50 ml of saline, followed by 500 ml of 4% paraformaldehyde (PFA) in
phosphate buffer. Then, the animals were guillotined, and the brain was post-
1
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fixed with 4% PFA for 2 h and left in 20% sucrose during 2 days.
Computational Model of the GHS-R1a-σ R Heteromer
The structure of σ R was modeled based on the recently released crystal
structure (PDB id 5HK1) [25]. The inactive conformation of human GHS-R1a
(UniProt: Q92847) was built using crystal structures of the neurotensin 1
receptor (PDB id 4XES for all parts of the receptor, and PDB id 3ZEV for the
C-terminal part of TM7 and helix 8) [26, 27]. The human neurotensin 1 receptor
and GHS-R1a share 33% of sequence identity and 51% of sequence similarity.
The “active-like” form of GHS-R1a was modeled by incorporating the active
features present in the crystal structure of the β -adrenergic receptor in complex
with G  (PDB id 3SN6), namely the internal halves of TMs 5 and 6  [28]. The
“active-like” model of GHS-R1a contains G  (PDB id 1AGR) [29]. The GHS-
R1a homodimer was constructed based on the symmetric TM5/6 protein-protein
interface observed in the crystal structure of the µOR (PDB id 4DKL) [30]. The
GHS-R1a-σ R complex was constructed using protein-protein docking with
HADDOCK [31], under the imposed experimental restrains that TMs 1 and 2 of
GHS-R1a contact the single TM of σ R.
Results
GHS-R1a Forms Heteromeric Complexes with σ R
Immunocytochemical assays were performed to detect whether colocalization
between GHS-R1a and σ R occurred in transfected HEK-293T cells. Cells were
transfected with cDNAs for σ R fused to YFP (0.75 µg cDNA) and for GHS-
R1a fused to Renilla luciferase (Rluc) (1.66 µg cDNA). In cells expressing only
σ R-YFP, the receptor was detected by YFP fluorescence, identifying σ R-YFP
mainly in intracellular structures. In HEK-293T cells expressing GHS-R1a-
Rluc, the GHS-R1a was detected by a specific primary anti-Rluc and secondary
Cy3 antibodies, being the receptor was detected in intracellular structures and at
the plasma membrane level. Interestingly, in HEK-293T cells co-expressing
σ R-YFP (0.75 µg cDNA) and GHS-R1a-Rluc (1.66 µg cDNA), colocalization
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GHS-R1a interacts with σ R to form σ R-GHS-R1a heteroreceptor complexes. a
HEK-293T cells expressing σ R-YFP, GHS-R1a-Rluc, or both were monitored by
the YFP fluorescence (green) or using a monoclonal anti-Rluc primary antibody
and a cyanine-3-conjugated secondary antibody (red). Colocalization is shown in
yellow. Nuclei were stained in blue with Hoechst (1/100). Scale bar 10 µm. b
Scheme of the BRET  assay using σ Rluc and GHS-R1a-GFP . c BRET occurs in
HEK-293T cells transfected with a constant amount of cDNA (0.075 µg) for
σ Rluc and increasing amounts of GHS-R1a-GFP  (from 0.5 to 3 µg cDNA) or
A R-GFP  (from 0.5 to 2.5 µg cDNA) as negative control. Values are the mean
(in milliBRET units: mBU) ± S.E.M. from six to eight different experiments
To identify a potential direct interaction between σ R and GHS-R1a, we
developed BRET experiments, transfecting a constant amount of cDNA for σ R-
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(0.5 to 3 µg cDNA). A saturation BRET curve was obtained, thus indicating a
specific interaction between σ R and GHS-1a (BRET  371 ± 38 mBU,
BRET  68 ± 23) (Fig. 1b, c). In contrast, when adenosine A R-GFP  (0.5 to
2.5 µg cDNA) was used as negative control instead of GHS-R1a receptor, a
linear plot with low BRET values was obtained.
Quaternary Structure of the Heteromeric Complex Between
σ R and GHS-R1a
We next addressed the quaternary structure of σ R-GHS-R1a complexes taking
advantage of the recent publication of the crystal structure of σ R in a trimeric
receptor arrangement. The macromolecular complex cannot be understood
without taking into account that the GHS-R1a receptor can form homomeric
interactions with GHS-R1a and/or heteromeric interactions with GHS-R1b [6,
7, 8]. Thus, to identify the TM interfaces involved in GHS-R1a-GHS-R1a
homodimerization, GHS-R1a-GHS-R1b heterodimerization and their TM-
interacting interfaces with σ R, we used synthetic peptides with the amino acid
sequence of individual 1-7 TM domains 1–7 helices of GHS-R1a fused to the
transactivator of transcription (TAT) peptide (exact sequences are provided in
supplementary Table 1). These cell-penetrating peptides interact with the TM
domain of membrane proteins and can selectively disrupt interactions between
proteins, i.e., GPCR protomers [32, 33]. These peptides were first tested in
HEK-293T cells expressing GHS-R1a-nYFP (0.75 µg cDNA) and GHS-R1a-
cYFP (0.5 µg cDNA) to explore whether bimolecular fluorescence
complementation (BiFC) occurs (approximately 4000 4,000 units of
fluorescence indicative of the formation of GHS-R1a-homodimer complexes).
Notably, in the presence of interference peptides, we observed that the
fluorescence decreased by twofold only with TM5 and TM6 peptides (Fig. 2a).
These results pointed to the TM 5/6 interface for GHS-R1a-GHS-R1a
homodimerization. Similar results were obtained for GHS-R1a-GHS-R1b
heterodimerization (TM 5/6 interface, Fig. 2b), despite the fact that GHS-R1b
isoform lacks TMs 6 and 7 relative to GHS-R1a. Interestingly, when cells were
transfected with cDNAs for GHS-R1a-nYFP, GHS-R1b-cYFP, and non-fused
GHS-R1a, fluorescence was reduced in the presence of TM4, TM5, and TM6
peptides (Fig. 2c). These results suggest an arrangement of protomers in which
homodimerization of GHS-R1a occurs via the TM 5/6 interface, whereas
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(Fig. 2d). The fluorescence decrease induced by the TM6 peptide of GHS-R1a
(in addition to TM4 and TM5, Fig. 2c) could indicate that this peptide also
restricts the interactions with the TM 4 of GHS-R1b (Fig. 2d).
Fig. 2
Effect of interfering peptides on the σ R-GHS-R1a interaction. a–c, e–g BiFC
complementation experiments were performed in HEK-293T cells transfected
with 0.75 µg cDNA for GHS-R1a-nYFP and 0.75 µg cDNA for GHS-R1a-cYFP
(a), with 0.75 µg cDNA for GHS-R1a-nYFP and 0.75 µg cDNA for GHS-R1b-
cYFP (b), with 0.75 µg cDNA for GHS-R1a-nYFP and 0.75 µg cDNA for GHS-
R1b-cYFP in the presence of 1.5 µg cDNA for GHS-R1a-nYFP (c), with 0.75 µg
cDNA for GHS-R1a-nYFP and 0.75 µg cDNA for σ R-cYFP (e), with 0.5 µg
cDNA for GHS-R1b-nYFP and 0.5 µg cDNA for σ R-cYFP (f), or with 0.75 µg
cDNA for GHS-R1a-nYFP and 0.75 µg cDNA for GHS-R1b-cYFP (g) in the
presence of 1.5 µg cDNA of GHS-R1a not fused. Prior to fluorescence
determination, cells were treated with each of the interfering peptides (TM1 to
TM7, 4 µM) during 4 h. Values are the mean ± S.E.M. from eight to 10 different
experiments. One-way ANOVA followed by Dunnett’s post hoc test showed a
significant effect of treatments versus control conditions. *p < 0.05, **p < 0.01,
and ***p < 0.001. d Structural model for the GHS-R1a-GHS-R1b heterotetramer
(GHS-R1a protomers: blue, GHS-R1b protomers: purple) viewed from the
extracellular side (scheme of the arrangement—top—and three-dimensional
model (—bottom—).h (left) Structural model consisting of a GHS-R1a
homodimer (GHS-R1a G -bound: light blue, GHS-R1a G -unbound: dark blue) in
complex with a σ R homotrimer (in red, orange, and yellow) coupled to G  (Gα
Ras-like domain: light gray, Gα alpha helical domain: green, Gβ: dark gray, and
Gγ: purple) viewed from the extracellular side. h (right) Same model as in panel h
(left) but viewed across the plane of the membrane. Proteins are displayed with a
transparent surface and a cartoon. TM helices are indicated by circles (1–7 in








Página 15 de 39http://eproofing.springer.com/journals_v2/printpage.php?token=ZlEKmfy4rwYN1hfm3SBYMUncDJtHTaH8JQKNMI5wJMI
Next, we investigated the GHS-R1a TM domains involved in the interaction
with σ R. Remarkably, in HEK-293T cells co-expressing GHS-R1a-nYFP
(0.75 µg cDNA) and σ R-cYFP (0.5 µg cDNA), fluorescence complementation
(4000 4,000 units, which confirms the formation of GHS-R1a-σ R complexes as
shown in confocal images (Supplementary Fig. 1A)) was significantly reduced
in the presence of TM1, TM2, or TM5 peptides; a marked tendency without
statistical significance in the case of TM6 peptide was also found (Fig. 2e). This
clearly indicates the existence of two different interacting interfaces between
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and the single TM helix of σ R. When similar experiments were performed with
σ R-cYFP (0.5 µg cDNA) and GHS-R1b-nYFP (0.5 µg cDNA), the fluorescent
signal (3500 3,500 units) decreased in the presence of TM1 and TM2 but not
TM5 or TM6 peptides (Fig. 2f),; it should be noted again that because GHS-
R1b lacks TMs 6 and 7 relative to GHS-R1a. All members of the GPCR family
retain analogous tertiary structures at the seven-helical-bundle domain; thus, we
hypothesized that TM 1/2 or TM 5/6 interfaces could be involved in the
interaction between the GPCRs and σ R. In addition, GPCR
homo/heteromerization must be taken into account to accommodate the σ
receptor in the trimeric structure elucidated from structural studies. To obtain
data in a more physiological set-upIn order to achieve useful data in more
physiological conditions, HEK-293T cells were transfected with cDNAs for
GHS-R1a-nYFP and σ R-cYFP in the presence of non-fused GHS-R1b. As
fluorescence complementation (5000 5,000 fluorescence units) was reduced
only by TM1 and TM2 (Fig. 2g),; our conclusion interpretation was that the
formation of the GHS-R1a-GHS-R1b heterotetramer via TM 4/5 and TM 5/6
interfaces (Fig. 2d) only permits σ R to interact with GHS-R1a via the free TM
1/2 interface. Proper interference action of TM-TAT peptides was tested by PLA
(Supplementary Fig. 1B). In fact, TM1 and TM2 TAT peptides blocked the
expression of GHS-R1a-σ R heteromers while the constituted by treatment with
the TM7 TAT did not affect the PLA signal.
Using structural details on TM interfaces of GPCR oligomers [22] and the
crystal structure of human σ R [23], together with the results from BiFC
experiments performed in the absence and presence of disrupting TM peptides,
we constructed a computational molecular model (see “Methods”) of the GHS-
R1a homodimer in complex with G  and σ R (Fig. 2h). The model of the GHS-
R1a homodimer contains two free TM 4/5 interfaces that would allow binding
of two GHS-R1b protomers (Fig. 2d).The crystal structure of σ1R, in which the
protein arranges as a homotrimer, suggests that the homotrimer may represent
the functional unit However, the structural model for σ R favors a homotrimer
[23]. Accordingly, we constructed a computational model consisting of the
GHS-R1 dimer, a σ R trimer, and a G protein that fits with the requirements of
the biochemical data and takes into account all available structural constraints
(Fig. 2g; see “Methods”). According to the experiments with GHS-R1a-derived
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and GHS-R1a through either the TM1/2 or the TM5/6 interfaces. Because GHS-
R1a and GHS-R1b also employ the TM5/6 interface for homo-
/heterodimerization, we assumed that at normal expression levels, TM1/2 is the
only possiblemost likely  interface for the GHS-R1-σ R complex, as TM5/6 is
occupied by the GHS-R1 homodimer/heterodimer. This model indicates that a
single GPCR protomer of GHS-R1a cannot simultaneously bind σ R via the TM
1/2 interface and a G protein due to a steric clash between the βγ subunits of G
and the intracellular voluminous C-terminal domain tail of σ R, containing a
rigid cupin-like β-barrel fold that forms the buried ligand-binding site and the
βγ subunits of G  (Supplementary Fig. S1). Thus, the minimal functional unit
requires a GHS-R1a homodimer in which one protomer binds the G protein, and
the second protomer is responsible for the binding of the σ R TM helix (Fig.
2h). Interestingly, this model predicts that the cytoplasmic domain of one
protomer of the σ R trimeric structure interacts with the α-subunit of G .
Cocaine Increases Colocalization of σ R and GHS-R1a at the
Cell Surface
As cocaine binds σ R [34], which establishes direct interactions with ghrelin
receptors as shown above, we hypothesized that cocaine affects ghrelin-
mediated signals. First, we investigated the effect of cocaine in GHS-R1a
expression. Immunocytochemical assays were performed in cells expressing
σ R and GHS-R1a after addition of cocaine (30 µM, 30 min). Figure 3a shows
that plasma membrane expression of σ R increased when these cells were
treated with a physiologically relevant dose of cocaine [35]. A similar increase
was observed when cells were incubated with the σ R agonist PRE-084
(100 nM, 30 min). The expression of GHS-R1a was not modified upon
treatment with cocaine or PRE-084 but, interestingly, colocalization of σ R and
GHS-R1a at the cell surface increased. Thus, cocaine and the σ R-specific
ligand PRE-084 are able to concomitantly affect co-expression of both receptors
at the cell surface. Second, we evaluated the effect of cocaine and PRE-084 on
the heteromerization of σ R and GHS-R1a. A tendency to increased energy
transfer (without reaching statistical significance) was observed in the presence
of cocaine (30 µM) or PRE-084 (100 nM) in HEK-293T cells transfected with
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Effects of cocaine on ghrelin-mediated signaling. a HEK-293T cells transfected
with 0.75 µg cDNA for σ R-YFP, 1.66 µg cDNA for GHS-R1a-Rluc, or both were
treated with 30 µM cocaine or 100 nM PRE-084, then were monitored by the YFP
fluorescence (green) or using a monoclonal anti-Rluc primary antibody and a
cyanine-3-conjugated secondary antibody (red). Colocalization is shown in
yellow. Nuclei were stained with Hoechst (blue). Scale bar 10 µm. b BRET in
HEK-293T cells transfected with 0.075 µg cDNA for σ R-Rluc and 1.5 µg cDNA
for GHS-R1a-GFP  and treated with 30 µM cocaine, 100 nM PRE-084, or vehicle
for 30 min. Afterwards, the energy transfer signal was measured. Values are the
mean ± S.E.M. of seven different experiments. One-way ANOVA followed by
Dunnett’s post hoc test did not show any significant effect of treatments versus
control. c–f HEK-293T cells were transfected with 1.66 µg GHS-R1a cDNA and
0.25 µg GHS-R1b cDNA and treated with 30 µM of cocaine (red), 100 nM of the
σ R agonist, PRE-084 (green), 2 µM of the GHS-R1a antagonist, YIL-781 (blue),
or vehicle (black). Cells were then treated with ghrelin 100 nM (in (c), cells were
treated with 0.5 µM forskolin (FK)). ERK1/2 phosphorylation (d) was analyzed
using an AlphaScreen®SureFire® kit (Perkin Elmer). Fluorescence of the
GCaMP6 sensor was used to monitor cytosolic calcium mobilization (e), and real-
time label-free DMR tracings (f) representing the picometer shifts of reflected
light wavelength were recorded in an EnSpire® Multimode Plate Reader
(PerkinElmer, Waltham, MA, USA). Values are the mean ± S.E.M. from eight to
11 different experiments. One-way ANOVA followed by Dunnett’s post hoc test
showed a significant effect of treatments versus forskolin (cAMP assays, (c)) or
control (pERK1/2 assays, (d)), and one-way ANOVA followed by Bonferroni’s
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Cocaine Inhibits GHS-R1a Signaling
We first evaluated the effect of cocaine and PRE-084 on GHS-R1a-mediated
signaling by measuring cAMP levels. HEK-293T cells endogenously express
σ R, but do not express ghrelin receptors [35]. Moreover, it is known that low
concentrations of GHS-R1b expression significantly increase GHS-R1a
signaling [21]. Thus, to analyze GHS-R1a signaling pathways in HEK-293T
cells, we co-expressed GHS-R1a (1.66 µg cDNA) with low amounts of GHS-
R1b (0.25 µg cDNA). Stimulation of these cells with ghrelin (100 nM) in the
presence of forskolin (0.5 µM) significantly decreased cAMP levels (Fig. 3c).
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www.guidetopharmacology.org ) [7]. The effect of ghrelin on forskolin-induced
cAMP levels was completely blocked by pretreatment with the GHS-R1a
selective antagonist YIL-781 (2 µM) (Fig. 3c). Interestingly, when cells were
treated with cocaine (30 µM, 15 min) or the σ R agonist (PRE-084, 100 nM,
15 min) prior to ghrelin stimulation, the decrease in cAMP levels was prevented
to the extent similar to the one occurring with the GHS-R1a selective antagonist
YIL-781 (Fig. 3c). This suggests that cocaine behaves as agonist of σ R and
inhibits GHS-R1a signaling as efficiently as the GHS-R1a selective antagonist
YIL-781 bound to the orthosteric binding site. Similar experiments were carried
out in HEK-293T transfected with another class A GPCR. When the adenosine
A R receptors were used instead of instead of GHS-R1a, neither ghrelin, nor
cocaine induced any effect (Supplementary Fig. 2A-B). Moreover, A  adenosine
receptor expressing HEK-293T cells treated with a selective agonist (R-PIA,
100 nM) showed a significant decrease in cAMP and increase in MAPK
phosphorylation that was abolished by the A  receptor antagonist (1 µM,
DPCPX) but not by cocaine or PRE-084 (Supplementary Fig. 2C-D).
Measurement of ERK1/2 phosphorylation in HEK-293T cells transfected with
GHS-R1a and GHS-R1b after stimulation with ghrelin shows an increase of
80% (Fig. 3d). Similarly to measurements of cAMP levels (Fig. 3c), the GHS-
R1a selective antagonist YIL-781 and the σ R agonists cocaine and PRE-084
inhibited ghrelin effects (Fig. 3d). This indicates that cocaine and PRE-084 not
only affect the α -dependent pathway, but also the βγ-dependent signaling.
Moreover, a characteristic trace of intracellular calcium transient levels was
obtained in HEK-293T cells expressing GHS-R1a, GHS-R1b, and σ R after
activation with ghrelin (Fig. 3e). The calcium signal was abrogated by the
selective ghrelin receptor antagonist and was reduced by cocaine and by PRE-
084. To further test the inhibitory effect of agonist binding to σ R in GHS-R1a,
we performed dynamic mass redistribution (DMR) recordings that measure the
changes in the wavelength of light passing through cell monolayer [36]. Once
again, the magnitude of the signaling by ghrelin significantly decreased in the
presence of YIL-781, cocaine ,and PRE-084 (Fig. 3f). We can, thus, conclude
that the GHS-R1a selective antagonist YIL-781, cocaine, and PRE-084
inhibited ghrelin effects, as measured by cAMP levels, ERK1/2
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Cocaine Inhibition of GHS-R1a Signaling Is Mediated by
σ R
To check whether cocaine inhibition of ghrelin-induced signaling was due to its
interaction with σ R, HEK-293T cells expressing GHS-R1a (1.66 µg cDNA)
and GHS-R1b (0.25 µg cDNA) were transfected with a siRNA designed to
knock down expression of σ R (3 µg siRNA). Cells incorporating siRNA
responded to 100 nM of ghrelin in both forskolin-induced cAMP determination
and ERK1/2 phosphorylation, with similar results to those in cells without
siRNA (Fig. 4a, b). However, in the presence of siRNA, cocaine or PRE-084
had no effect on ghrelin-induced signals while pretreatment with YIL-781
blocked ghrelin-induced GHS-1a activation. Also, when HEK-293T cells
expressing GHS-R1a were transfected with siRNA against σ R, ghrelin induced
a characteristic signal on calcium mobilization or on DMR recordings.
Similarly, these stimulations were not affected by cocaine or PRE-084
pretreatment, while they were completely blocked by the ghrelin antagonist
YIL-781 (Fig 4c,d). These results show that cocaine effects on GHS-R1a
receptor are mediated by σ R.
Fig. 4
Effects of cocaine on GHs-R1a signaling are dependent on σ R expression. a–d
HEK-293T cells were transfected with 1.66 µg GHS-R1a cDNA, 0.25 µg GHS-
R1b cDNA, and 3 µg siRNA for σ R. These cells were treated with 30 µM of
cocaine (red), 100 nM of the σ R agonist, PRE-084 (green), 2 µM of the GHS-
R1a antagonist, YIL-781 (blue), or vehicle (black) followed by 100 nM of ghrelin
stimulation (in (a), cells were treated with 0.5 µM forskolin). cAMP levels (a),
pERK1/2 (b), calcium ion (c), and DMR (d) signals were recorded. Values are the
mean ± S.E.M. from eight to 11 different experiments. One-way ANOVA
followed by Dunnett’s post hoc test showed a significant effect of treatments
versus forskolin (cAMP assays, (a)) or control (pERK1/2 assays, (b)), *p < 0.05,
**p < 0.01, and one-way ANOVA followed by Bonferroni’s post hoc test showed
a significant effect of treatments versus ghrelin, ##p < 0.01. e–f HEK-293T cells
expressing GHS-R1a (0.5 µg cDNA) were treated for 4 h with TM1 (e, f) or TM7
(g, h) TAT-peptides. Cells were subsequently treated with 30 µM cocaine (red),
100 nM PRE-084 (green), 1 µM YIL-781 (blue), or vehicle (black). Cells were
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forskolin). Traces representing DMR signal variation over time are represented in
f and h. Values are the mean ± S.E.M. of six different experiments. One-way
ANOVA followed by Dunnett’s post hoc test showed a significant effect of
treatments versus forskolin, *p < 0.05, **p < 0.01, and ***p < 0.001, and one-way
ANOVA followed by Bonferroni’s post hoc test showed a significant effect of
treatments versus ghrelin, #p < 0.05 and ###p < 0.001
31/5/18 11'43e.Proofing
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Disruption of the Heteromeric Complex Between σ R and
GHS-R1a by the TM1 Interference Peptide Blocks the Effect
of Cocaine on GHS-R1a Function
As proposed above from data using TAT-fused synthetic peptides, the single TM
helix of σ R likely interacts with TMs 1 and 2 of GHS-R1a. Accordingly, we
can hypothesize that addition of the TM1 interference peptide would abolish the
effect of cocaine on GHS-R1a function. Thus, HEK-293T cells expressing
GHS-R1a (1.66 µg cDNA) were treated during 4 h with 4 µM of TAT-TM1 (or
TAT-TM7 as negative control). In agreement with our hypothesis, disruption of
σ R-GHS-R1a heteromeric complex was achieved by TM1, but not
by TM7 TAT peptides; in these experimental conditions in which TM1 peptide
was present, only the GHS-R1a selective antagonist YIL-781 (1 µM) blocked
ghrelin (100 nM) stimulation, whereas cocaine (30 µM) or PRE-084 (100 nM)
did not display any effect on either cAMP levels (Fig. 4e, g) or DMR signals
(Fig. 4f, h). These results demonstrate that disruption of the GHS-R1a-σ R
interaction using TM1 alters the cocaine effect on ghrelin receptors, thus
reinforcing the idea that cocaine modulates GHS-R1a receptor function via σ R.
Next, we attempted to provide insight into the mechanism by which cocaine
binds to σ R and blocks GHS-R1a function. Our structural model predicts that a
single protomer of GHS-R1a cannot simultaneously bind σ R (via the TM 1/2
interface) and G  (supplementary Fig. S1); accordingly, σ R may impede G
binding and, in consequence, GHS-R1a function. However, this does not seem
reasonable due to the possible formation of a GHS-R1a homodimer in which
one protomer binds G  and the second protomer binds σ R (Fig. 2h). Notably,
this model positions the cytoplasmic domain of one protomer of the σ R
trimeric structure near the α-helical domain (αAH) of the G protein α-subunit
(Fig. 2h). It has been shown that the mechanism for receptor-catalyzed
nucleotide exchange in G proteins involves a large-scale opening of αAH, from
the Ras domain, allowing GDP to freely dissociate [37]. This opening of αAH is
not feasible in the presence of the σ R trimeric structure bound to TMs 1 and 2
of GHS-R1a. Modification of the GHS-R1a-σ R interaction, by inserting the
TAT-fused TM1 peptide, would increase the distance between cytoplasmic
domain of σ R and αAH, facilitating Gi function, and these were the results
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Effect of Cocaine Treatment on a Cell Line and on Primary
Cultures of Striatal Neurons
Most of the cocaine effects in the central nervous system (CNS) occur in the
striatum [38, 39]. Consequently, we analyzed cocaine effects on GHS-R1a
expressed in the SH-SY5Y neuroblastoma cell line. Cells were transfected with
cDNAs for GHS-R1a (1.66 µg), GHS-R1b (0.25 µg), and σ R (0.75 µg). The
results were similar to those obtained in HEK-293T cells, i.e., cocaine and PRE-
084 specifically blocked ghrelin action on cAMP levels and ERK1/2
phosphorylation (Fig. 5a, b). Pretreatment with the ghrelin receptor antagonist,
YIL-781, also blocked ghrelin effects in neuroblastoma cells. Then, we moved
to primary cultures of striatal neurons to analyze in a more physiological
environment the cocaine effects over GHS-R1a receptors. The in situ proximity
ligation assay (PLA), which allows the identification of interactions between
two proteins in close proximity (< 17 nm) [10, 40, 41] was used to identify
GHS-R1a-σ R complexes, detected as punctate red marks surrounding Hoechst-
stained nuclei (Fig. 5a). In striatal primary cultures, 43% of cells presented red
dots with two dots/cell-containing dots. However, when these cells were treated
with 30 µM cocaine for 30 min, the number of cells containing red dots and the
number ratio of dots/cell-containing dots increased significantly (54% of cells
presented red dots with 3.2 dots/cell-containing dots). These results indicate
that cocaine pretreatment increases GHS-R1a-σ R complex formation 
expression in striatal primary cultures (Fig. 5a, b). Cocaine effects on GHS-R1a
signaling were further analyzed in primary cultures of striatal neurons, both in
cAMP level determination and in ERK1/2 phosphorylation assays. Cocaine and
PRE-084 counteracted the ghrelin-induced  ghrelin-induction of GHS-R1a
signaling in a similar way as the GHS-R1a-specific antagonist YIL-781 (Fig.
5c, d). Such effect of cocaine was related to σ R modulation of GHS-R1a, as in
striatal primary cultures treated with siRNA for σ R, neither cocaine nor PRE-
084 achieved any significant effect (Fig. 5e, f).
Fig. 5
Cocaine treatment inhibited GHs-R1a signaling in primary cultures of striatal
neurons. a, b SH-SY5Y cells were transfected with cDNAs for GHS-R1a
(1.66 µg), GHS-R1b (0.25 µg), and σ R (0.75 µg). Assays were performed in
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agonist, PRE-084 (green), 2 µM of the GHS-R1a antagonist, YIL-781 (blue), or
vehicle (black) prior to 100 nM ghrelin addition. cAMP levels were determined
after 15 min of 0.5 µM forskolin treatment (a). ERK1/2 phosphorylation (b) was
determined using an AlphaScreen®SureFire® kit (Perkin Elmer). Values are ±
S.E.M. from five to six different experiments. One-way ANOVA followed by
Dunnett’s post hoc test showed a significant effect of treatments versus forskolin
(cAMP assay) or versus control (ERK phosphorylation assay), *p < 0.05, **p < 
0.01, and ***p < 0.001, and one-way ANOVA followed by Bonferroni’s post hoc
test showed a significant effect of treatments versus ghrelin, ##p < 0.01 and ###p 
< 0.001. In c, d, GHS-R1a-σ R heteroreceptor complexes were identified in
striatal primary cultures treated with 30 µM cocaine, 100 nM PRE-084, or vehicle
and detected by PLA (see “Methods”) using a polyclonal anti-σ R primary
antibody (1/100, Santa Cruz Biotechnology, Dallas, US) and a polyclonal anti-
ghrelin primary antibody (1/100, AbCam, Cambridge, UK). Nuclei were labeled
using Hoechst (1/100). c Representative confocal images showing GHS-R1a-σ R
complexes as red dots surrounding Hoechst-stained nuclei. Scale bar, 5 µm. d
Percentage of positive cells (containing one or more red dots in cells in five–six
different fields), and number (r) of red dots/cell-containing dots in primary
cultures of striatal neurons. One-way ANOVA followed by Dunnett’s post hoc test
showed a significant effect of treatments versus the negative control, *p < 0.05,
**p < 0.01, and one-way ANOVA followed by Bonferroni’s post hoc test showed
a significant effect of treatments versus the untreated cells, #p < 0.05. e, f Striatal
primary cultures transfected (f) or not (e) with 3 µg siRNA for σ R were treated
with 30 µM cocaine (red), 100 nM of the σ R agonist, PRE-084 (green), 2 µM of
the GHS-R1a antagonist, YIL-781 (blue), or vehicle (black) prior to 100 nM
ghrelin addition. ERK1/2 phosphorylation (e, f) was analyzed using an
AlphaScreen®SureFire® kit (Perkin Elmer). Values are ± S.E.M. from six to
eight different experiments. One-way ANOVA followed by Dunnett’s post hoc
test showed a significant effect of treatments versus control, *p < 0.05, **p < 0.01,
and ***p < 0.001, and one-way ANOVA followed by Bonferroni’s post hoc test
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Effect of Cocaine Administration on GHS-R1a-σ R
Heteromer Expression in Striatal Sections from Naïve and
Cocaine-Treated Animals
Following i.p. administration of 15 mg/kg cocaine for 1 (acute) or 14 (chronic)
days, rats were sacrificed, and 30 µm thick striatal sections were obtained from
each group of animals and from vehicle-treated animals. The in situ proximity
ligation assay (PLA) was used to identify GHS-R1a-σ R heteroreceptor
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analyzed, it was observed that 11% of cells showed red dots with 1.6 dots/cell-
containing dots (Fig. 6b), indicating that around 10% of striatal cells expressed
GHS-R1a-σ R complexes. Interestingly, in the case of the chronic treatment, the
number of cells containing dots strongly increased to 61%, and also, the number
of dots/cell-containing dots (2.7) was significantly higher compared to control
cells. Remarkably, the cocaine acute treatment leads to values that were even
higher than in the chronic condition (76% of cells containing dots and 3.2
dots/cell-containing dots). These results indicate that cocaine treatment
modulated GHS-R1a-σ R complex formation in striatal rat sections with a
maximum increase in heteromer formation found in acute conditions (Fig. 6b).
Fig. 6
Acute and chronic cocaine treatment increase the GHS-R1a-σ R heteromer
expression in the rat striatum. Male Sprague-Dawley rats were i.p. administrated
with vehicle (control) or 15 mg/kg cocaine for 1 (acute) or 14 (chronic) days. To
identify σ1-GHS-R1a complexes from each condition, rats were sacrificed and
30 µm thick striatal sections were obtained and treated with a polyclonal anti-σ R
primary antibody (1/100, Santa Cruz Biotechnology, Dallas, US) and a polyclonal
anti-ghrelin primary antibody (1/100, AbCam, Cambridge, UK) in the presence of
Hoechst (1/100) and then treated with the PLA probes (see “Methods”).
Representative PLA confocal images showing GHS-R1a-σ R complexes as red
dots surrounding Hoechst-stained nuclei are shown for each condition (Fig. 6a).
Scale bar, 5 µm. b Percentage of positive cells (containing one or more red dots;
from cells in four–six different fields) and number (r) of red dots/cell-containing
dots in rat striatal sections. One-way ANOVA followed by Dunnett’s post hoc test
showed a significant effect of treatments versus the negative control, *p < 0.05,
**p < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test showed a
significant effect of treatments versus the untreated cells, ###p < 0.001, and one-
way ANOVA followed by Bonferroni’s post hoc test showed a significant effect
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Discussion
The endogenous ligand of σ R remains unknown; however, synthetic agonists
and antagonists are available. PRE-084 is a selective agonist due to its ability to
dose-dependently dissociate σ R from a binding immunoglobulin
protein/78 kDa glucose-regulated protein (BiP/GPR-78) [42]. Despite not being
associated with a specific signaling machinery, σ R operates via translocation to
the plasma membrane and via protein-protein-mediated modulation of cell
responses upon agonist activation [11]. The mechanism involves calcium
signaling and ion channel activation [43], and, in addition, to the regulation of
GPCRs function[11]. For instance, it has been shown that σ R is involved in the
negative control that glutamate N-methyl-D-aspartate acid receptors (NMDARs)
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antagonists would enhance antinociception and reduce neuropathic pain induced
by µ-opioid receptors. Another remarkable example is the control of σ R in the
interaction between cannabinoid CB1 and NMDAR receptors, whose failure
functional unbalance constitutes a vulnerability factor for cannabis abuse,
potentially precipitating schizophrenia [44]. Upon demonstrating that cocaine
binds to σ R even at doses attained at recreational use, σ R is proposed to
mediate locomotor activation [45, 46], seizures [18], drug sensitization [47],
and reward actions [48, 49]. Reduction of σ R levels by injection of antisense
nucleotides results in attenuating the convulsive effects of the drug [50],
whereas the action of σ R agonists or antagonists exacerbates or minimizes,
respectively, cocaine effects [50, 51, 52]. Although activation of σ R by
agonists is also involved in the appetitive properties of cocaine [49], the
underlying mechanism remains unknown. In this manuscript, we reveal for the
first time that σ Rs mediate the hunger-suppressivehunger-suppressive action of
cocaine by interacting with orexigenic ghrelin receptors.
The nucleus accumbens, one of the structures that form the striatum, is part of
the reward system. Activation of this system in response to food intake
produces a pleasant sensation and other primordial needs for mammalian
survival [53]. It should be noted that in these mesolimbic regions, GHS-R1a is
co-expressed in neurons with cocaine-sensitive σ R. From both mechanistic and
molecular point of views, this report highlights an interaction between σ R and
GHS-R1a that is translated into a strong inhibition of ghrelin-induced GHS-R1a
signaling, as measured by G protein-dependent (cAMP accumulation and
calcium release assays) and partly/fully G protein-independent (MAPK
phosphorylation and dynamic mass redistribution assays) signaling pathways.
We have shown in transfected HEK-293T cells and in striatal primary cultures
of neurons that pretreatment with the σ R agonists cocaine or PRE-084 inhibits
ghrelin-mediated signaling in a similar manner as the GHS-R1a antagonist YIL-
781. This effect is mediated by σ R, because, in σ R-siRNA-treated cells,
cocaine or PRE-084 had no effect on ghrelin-induced signals while the ghrelin
receptor antagonist, YIL-781, maintained its effect.
Kotagale and collaborators [54] have described the potent orexigenic effects of
neuropeptide Y (NPY), which was described in autoradiographic studies [55] as












Página 30 de 39http://eproofing.springer.com/journals_v2/printpage.php?token=ZlEKmfy4rwYN1hfm3SBYMUncDJtHTaH8JQKNMI5wJMI
linking the stimulation of sigma receptors with hunger. It turned out that the
action of NPY on sigma receptors could not be reproduced, i.e., no high affinity
binding of NPY to brain sigma receptors can be measured [56]. Our results
show that cocaine binding to σ R could counteract the feeling of hunger by a
mechanism that excludes a direct competition between cocaine and NPY to
interact with σ R. The proposed formation of the σ R-GHS-R1a interaction
becomes even more important by the finding that heteromer expression is
increased in both acute and chronic cocaine administration. However, the effect
was more marked in acute conditions. In fact, striatal sections of Sprague-
Dawley rats injected for 1 day with 15 mg/kg cocaine displayed threefold
higher expression of σ R-GHS-R1a heteromers than the control animals.
The structure of σ R has traditionally considered to be formed by two TM
helices. However, the recently released crystal structure of σ R has shown
homotrimers whose protomers contain a single TM domain and a C-terminal
taildomain  having a buried ligand-binding site that arranges into homotrimers
[25]. We have proposed, from data using TAT-fused synthetic peptides together
with BiFC assays, that this single TM helix of one σ R molecule can be
recognized by two different interacting interfaces of the 7TM bundle of GHS-
R1aGPCRs, either by interfaces formed by TMs 1 and 2 or TMs 5 and 6.
Oligomerization of GPCRs via a particular interface likely guides the
interacting interface in the σ R. The same TM helices may be involved in
interactions of σ1R with other GPCRs. In the particular case of σ R-GHS-R1a,
due to the formation of the GHS-R1a-GHS-R1b heterotetramer via TM 4/5 and
TM 5/6 interfaces, σ R can interact with GHS-R1a via the free TM 1/2
interface. We would like to speculate that, because σ R is a homotrimer, the two
additional TM helices can bind two additional GHS-R1a-GHS-R1b
heterotetramers, suggesting the possible existence ocurrence of higher order
complexes formed by between GHS-R1a and σ R, produced by the successive
combination of these units. These clusters may form specialized machineries of
σ R-mediated signaling.
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Effect of interfering peptides on the σ R-GHS-R1a expression in HEK-293 T
cells. Panel A: BiFC complementation experiments were performed in HEK-
293 T cells transfected with 0.75 µg cDNA for GHS-R1a-nYFP and 0.75 µg
cDNA for σ R-cYFP (right panel). Fluorescence due to reconstituted YFP was
detected in a Leica SP2 microscope. Nuclei were stained with Hoechst (1/100).
As negative control (left panel), BiFC complementation experiments were
performed in HEK-293 T cells transfected only with 0.75 µg cDNA for σ R-
cYFP. Scale bar 5 µm. Panel B: PLA assays in HEK-293 T cells expressing σ R
(0.75 µg of plasmid) and GHS-R1a (1.66 µg of plasmid) treated for 4 h with TM1,
TM2 or TM7 TAT peptides prior to incubation with a polyclonal anti-σ R primary
antibody (1/100, Santa Cruz Biotechnology, Dallas, US) and a polyclonal anti-
ghrelin primary antibody (1/100, AbCam, Cambridge, UK). Nuclei were labeled
using Hoechst (1/100). GHS-R1a-σ R complexes are shown as red dots
surrounding Hoechst-stained nuclei. Scale bar 10 µm. (GIF 283 kb)
Hight resolution image (TIF 15132 kb) Missing all Supplementary figs. Do you
need them?
Supplementary Figure 2
Effects of cocaine on A  adenosine receptor-mediated signaling. In A-D, HEK-
293 T cells were transfected with 1 µg of cDNA for A R and 0.75 µg cDNA for
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PRE-084 (green), 2 µM of the GHS-R1a antagonist, YIL-781 (blue), (A,B) or the
A R antagonist (1 µM DPCPX, pink) (C,D) or vehicle (black). Cells were then
treated with 100 nM ghrelin (A,B) or the A R agonist (100 nM R-PIA). In panels
A and C, cells were treated with 0.5 µM forskolin (FK) prior to cAMP level
determination. ERK1/2 phosphorylation (B and D) was analyzed using an
AlphaScreen®SureFire® kit (Perkin Elmer). Values are the mean ± S.E.M. from 6
to 8 different experiments. One-way ANOVA followed by Dunnett’s post-hoc test
showed a significant effect of treatments versus forskolin (cAMP assays, panel A,
C) or control (pERK1/2 assays, panel B, D), *p < 0.05 and ***p < 0.001. (GIF
114 kb)
Hight resolution image (TIF 2341 kb)
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